Pyridine-containing compound biosynthetic process

pathway activity — cross-omics
GO:0072525Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyridine-containing compound biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the HNSC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CD274, CCRL2, and HCST, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyridine-containing compound biosynthetic process activity versus CD274 in HNSC (Pearson r = 0.27).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCCD274 →+0.940+0.217.005.00136
GBMCCRL2 →+0.702+0.146<.001.00136
OVHCST →+0.736+0.240<.001<.00136
GBMLILRB2 →+0.979+0.173<.001<.00136
OVGNLY →+1.408+0.282.001<.00136
LUADABI3 →+0.435+0.206.003.00536
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072525 vs CD274 — HNSC

Per-sample scatter of Pyridine-containing compound biosynthetic process activity vs CD274 in HNSC.

Explore this scatter interactively →

Exploration